Long COVID | Public Health and CDC/FDA Updates | April 5, 2021
Date of Presentation: April 5, 2021
Type: Past Presentation
Audience: Clinical
Program: Virology
Keywords: #long haul covid #public health updates
In this series of presentations, Dr. Thomas Becker, Medical Epidemiologist and ECHO faculty member, reviews the latest articles on COVID-19 long haulers (including children). Then, Dr. Eileen M. Dunne, PhD, ECHO faculty member and Epidemic Intelligence Service Officer for the Centers for Disease Control and Prevention at the Idaho Division of Public Health, provides a public health practice update and a number of valuable COVID-19 related resources produced by HHS, CDC and FDA.
Recording:
Presented by:
Dr. Thomas Becker, Dr. Eileen M. Dunne
Thomas Becker, MD, PhD, is a medical epidemiologist, and trained in internal medicine, anthropology, and public health; he began his career at the University of New Mexico before moving to the Northwest about 20 years ago. Since his arrival in Portland, Becker has worked with the Northwest Portland Area Indian Health Board and Oregon Health & Science University. He has published on a diverse range of American Indian health issues, including both infectious and chronic diseases. And with the Indian Health Board, he has been involved in etiologic studies, community prevention programs and education programs to improve career opportunities for people in tribes nationwide.
Eileen M. Dunne, PhD, is an Epidemic Intelligence Service Officer with the Centers for Disease Control and Prevention assigned to the Idaho Department of Health & Welfare. Eileen has a Ph.D. in microbiology from Boston University and spent nine years at the Murdoch Children’s Research Institute in Melbourne, Australia conducting clinical research on pediatric infections and pneumococcal vaccines. Her primary interests include infectious diseases, immunization, and public health.
Resources Provided:
- Long COVID (Presentation Slides)
- Public Health Updates (Presentation Slides)
- Limited recovery from post-acute sequelae of SARS-CoV-2 (PASC) at eight months of a prospective cohort (Pre-print medRxiv)
- Post-COVID syndrome in individuals admitted to hospital with COVID-19: retrospective cohort study (BMJ)
- Long-term health consequences of COVID-19 (viewpoint in JAMA)
- Buonsenso et al. 2021
- Post-acute sequelae of COVID-19 in a non-hospitalized cohort: results from the Arizona CoVHORT
- Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19 (Acta Paedia)
- Symptoms of Anxiety or Depressive Disorder and Use of Mental Health Care Among Adults During the COVID-19 Pandemic — United States, August 2020–February 2021 (MMWR)
- Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021 (MMWR)
- Death Certificate–Based ICD-10 Diagnosis Codes for COVID-19 Mortality Surveillance — United States, January–December 2020 (MMWR)
- Provisional Mortality Data — United States, 2020 (MMWR)
- FDA authorizes revisions to fact sheets to address SARS-CoV-2 variants for monoclonal antibody products under EUA (FDA)
- Media Statement from CDC Director Rochelle P. Walensky, MD, MPH, On COVID-19 Vaccination at Dialysis Centers (CDC)
- CDC People with Certain Medical Conditions (CDC)
- Bamlanivimab updates (FDA)
- Bamlanivimab and Etesevimab updates (FDA)
- REGEN-COV (Casirivimab and Imdevimab) updates (FDA)
- FDA Continues to Advance Over-the Counter and Other Screening Test Development (FDA)
- Biden Administration to Invest More Than $12 Billion to Expand COVID-19 Testing (HHS)
- CDC Plans to Provide $332 Million to Support Community Health Workers for COVID-19 Prevention and Control (CDC)
Date added: April 5, 2021